# Codex Review: medical_monitoring_ai_confidence_gate_20260803

Date: 2026-08-03
Delegated-agent output: none (Codex-only bounded slice; Hermes worker was not dispatched)

## Verdict

Pass for this bounded contract slice; not a release or clinical-automation acceptance.

## Boundary Check

- No delegated agent or external provider was started.
- Changes are confined to the workbench backend/frontend source, tests, and this task's context/review/metrics records.
- No service, browser login, real project import, provider transport, B6/C14 activation, migration, or release write was performed.

## Codex Verification

- `py_compile` passed for all modified Python modules and the new confidence-contract test.
- Backend focused suite passed: 502 tests (`tests/test_monitoring_ai_api.py`, `tests/test_monitoring_ai_service.py`, `tests/test_monitoring_protocol_preparation.py`, `tests/test_monitoring_rule_template_recommendation.py`); the confidence/protocol/rule-template subset passed 71 tests, including the temporary low-confidence acceptance probe.
- All 23 medical-monitoring frontend `*.test.mjs` modules passed, including 32 protocol-preparation and 24 rule-template recommendation assertions.
- `npm run build` passed; Vite emitted only the pre-existing large-chunk advisory.
- Public candidate serializers now include the shared confidence summary; all paths report `automation_permitted=false`.
- Low/malformed confidence requires a non-empty human explanation before acceptance in generic AI, protocol preparation, and rule-template recommendation routes; the UI exposes the evidence/confirmation field.
- A temporary protocol-candidate fixture regression sets one claim to 0.40 and confirms blank-reason acceptance is rejected; gates run only while the candidate is still proposed so accepted-decision replay remains possible.
- No live browser or real-project check was appropriate for this slice because the standing boundary keeps 8911/5174/8910/4173 and real project runs stopped.

## Hermes / Delegated-Agent Output Review

Not applicable. The implementation was reviewed directly against the source contracts and adjacent acceptance surfaces. The 0.70 threshold is explicitly documented as governance/presentation only, not a calibrated clinical probability.

## Residual Risk

- Confidence values are still model/provider claims and are not clinically calibrated by this patch; later real-provider evaluation must establish task-specific performance and uncertainty evidence.
- No real provider, Playwright login, scientific review, or two-clean-round UAT evidence exists yet; the commercial release gate remains blocked.
- B6 formal reviewer outcomes, CAS replay, source-token revalidation, C14 activation, and release dossier authority remain pending/false.
